Replies to post #270064 on Avid Bioservices Inc (CDMO)

[geocappy1]

Let's hope so. If the science works in I-O, the BPs should take it from there.

Does anybody have any clue on why we would not acknowledge ou BBs patent and/or potential? Are they trying to hide it while they try to monetize bavi?

[Wernaaa]

I just hear "during the next CC, during the next and the next...". Next ASCO....

Can remember, that some experts on this board said, that we get an update during the next CC.....

[Protector]

horselover45, it will not be for the next CC it will be at the earliest for OCT 2016.

The next CC will have news for Avid, no doubt, and a progression on the Exosome test. A Sunrise follow-up update may be PRed BEFORE the next Q/CC.

Wolchok's Lab results might be for Q4/2016 (calendar) but it depends on publications/schedules.

PPHM HAS in its possession at this time MUCH MORE detailed information on the Yervoy+Bavituximab in melanoma. Not sure how this will be played, we are talking about a CTLA-4 + Bavituximab and we are talking about a BMY drug, two parameters to consider strategically.

[Couch]

I agree legit news centered around IO data!

AVID is nice but it shouldn't be the bread and butter - and right now it certainly is.